Targeted therapy Archives | Page 2 of 2

Possible New Treatments for Patients With Metastatic HER2-Positive Breast Cancer

Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options.

by Marci A. Landsmann
First Immunotherapy Approved for Breast Cancer

Medical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.

by Anna Azvolinsky
Treating Cancer Based on Its Genetics, Not Its Location

Medical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.

by Anna Azvolinsky

Previous |

Lesbians, bisexual women and transgender men had a longer wait for diagnosis and a higher risk of recurrence.

by Jon Kelvey

Researchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.

by Marci A. Landsmann

Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.

Men are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.

by Kyle Bagenstose

Cancer Talk Archive

Cancer Talk Topics

From the AACR

The Many Aspects of Early Detection and Interception of Cancer

Early detection is key to improving outcomes from cancer. Research in cancer interception aims to characterize tumors at the earliest stages of development.
Translating Personal Tragedy Into the Search for New Cancer Therapeutics

Dr. Patricia LoRusso’s parents both died of cancer when she was a teenager, inspiring her to become an oncologist and develop new treatments for people with cancer.

Bringing Cancer Research to Life: Elizabeth M. Jaffee, MD, FAACR